• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID Back to Search Results
Catalog Number PC0520RXC
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/14/2019
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing documentation associated with lot 17775355 presented no issues during the manufacturing process that can be related to the reported event.This device is available for analysis but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.
 
Event Description
As reported, it was found that a precise pro rx self-expanding stent (ses) got deployed little before usage.The device was not used.There was no reported patient injury.The intended procedure was carotid artery stenting (cas).The product was stored properly according to the instructions for use (ifu) and there was nothing unusual noted about the stent delivery system prior to use.The product was prepped properly according to the ifu and it was prepped in the tray.The tuohy borst valve was closed prior to removing the device from the tray.The procedure was completed with a new precise pro rx ses.The device is expected to be returned for analysis.
 
Manufacturer Narrative
It was found that a precise pro rx self-expanding stent (ses) got deployed a little before usage.The device was not used.There was no reported patient injury.The intended procedure was carotid artery stenting (cas).The product was stored properly according to the instructions for use (ifu) and there was nothing unusual noted about the stent delivery system prior to use.The product was prepped properly according to the ifu and it was prepped in the tray.The tuohy borst valve was closed prior to removing the device from the tray.The procedure was completed with a new precise pro rx ses.The product was returned for analysis.One non-sterile precise pro rx us carotid system stent delivery system was received for analysis inside a plastic bag.Per visual analysis no original packaging was returned.The valve of the unit was received partially locked/ closed.The stent of the unit was received already fully deployed.The stent delivery system was damaged at 25.6 cm, at 36.7 cm, and at 139.9 cm from tip.There was a kink at 145.8 cm from tip, on the id band area, at the level of juncture of body to the valve of the delivery system.However, it could not be determined if the compressed and kinked conditions were produced during the reported event or during the transportation of the returned unit.The deployed stent was thoroughly inspected, and no anomalies were observed that could contributed to the reported event.No other anomalies found.Functional analysis could not be completed due to the stent having been deployed previously.Per dimensional analysis the device was within specification.A product history record (phr) review of lot 17775355 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿stent delivery system (sds)-ses deployment difficulty - premature/during prep¿ could not be confirmed as the device could not be evaluated due to the condition of the device being deployed and without the provision of procedural images for review.The exact cause could not be determined.Procedural or handling factors may have contributed to the reported event as evidenced by kinks and compressions, and the deployment of the stent, noted on the device during analysis.According to the instructions for use, which is not intended as a mitigation of risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.¿ neither the phr nor the limited information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
MDR Report Key8975183
MDR Text Key198348563
Report Number9616099-2019-03191
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036389
UDI-Public20705032036389
Combination Product (y/n)N
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Catalogue NumberPC0520RXC
Device Lot Number17775355
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/03/2019
Date Manufacturer Received09/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-